Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is unchanged from the same period last year.
Related Posts
GM Partners With OneD To Increase Energy Density & Reduce Cost Of EV Batteries
General Motors Co (NYSE:GM) is partnering with EV battery technology firm, OneD Battery Sciences for a joint research development agreement. GM Ventures…
Marine Products Q3 EPS $0.34 Up From $0.20 YoY, Sales $100.06M Up From $75.84M YoY
Marine Products (NYSE:MPX) reported quarterly earnings of $0.34 per share. This is a 70 percent increase over earnings of $0.20 per share from the same period last year. The company reported $100.06 million in sales
GitLab: Q1 Earnings Insights
GitLab (NASDAQ:GTLB) reported its Q1 earnings results on Monday, June 5, 2023 at 04:05 PM. Here’s what investors…